“National Hiring Event Offering Nearly 1,000 Opportunities to Live the “Merry Maids Life” Positions available across the country as company expands to meet demand for home cleaning services ”
“ announced today that the U.S. Food and Drug Administration (FDA) approved Praluent® (alirocumab) Injection, the first FDA-approved treatment in a new class of drugs known as PCSK9 (proprotein convertase subtilisin/kexin type 9) inhibitors. Praluent is indicated as an adjunct to diet and maximal
“The Eeva Test is a first-in-class, non-invasive predictive test that enhances the embryo selection process by taking images of the embryos during the incubation period. The Test uses proprietary time-lapse image analysis software that was developed to take advantage of a scientific discovery at t
1
National Hiring Event Offering Nearly 1,000 Opportunities to Live the “Merry Maids Life”
Plan for What will Happen, not What might Happen
Sanofi and Regeneron Announce FDA Approval of Praluent® (alirocumab) Injection, the First PCSK9 Inhibitor in the U.S., for the Treatment of High LDL Cholesterol in Adult Patients
The Eeva™ Test is Now Available to Help IVF Patients in the United States
